Time is flying, and we are already five months into the year. Thirteen novel drugs have been approved by the FDA so far in 2018 - with 4 being greenlighted in the month of May. Now, let's take a look at the biotech stocks that await FDA word in June 2018.
from RTT - Biotech https://ift.tt/2sfe2CQ
via IFTTT
No comments:
Post a Comment